Skip to main content
LabcorpPartnership

Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential

Source: Autobound Signal API · 76 signals tracked for Labcorp · updated

Get Labcorp's live signals in Claude or ChatGPT, or by API

AskWhat changed at Labcorp this week? Use Autobound signals for labcorp.com.

What happened

Labcorp announced a research collaboration with Charles River Laboratories and the FDA to advance preclinical methods for evaluating drug abuse potential.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Research collaboration aims to strengthen the science used to assess whether new medicines could be abused, supporting safer drug development and more informed regulatory decisions BURLINGTON, N.C., Oct. 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH ), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the U.S. Food and Drug Administration (FDA) and Charles River Laboratories to advance the science used to evaluate a medicine's abuse potential, or the likelihood that it could be abused. The research aims to support safer drug development and more informed regulatory decisions. The collaboration brings together complementary expertise from industry and government. Labcorp will contribute its experience conducting regulatory abuse potential studies, while FDA scientists will conduct data analysis and contribute regulatory science expertise. Together, the organizations aim to advance the science used to evaluate the risk that a medicine could be abused using harmonized behavioral economics methodology to quantify and rank abuse potential. "This research has the potential to improve how abuse-related risks are evaluated and inform decisions throughout drug development and regulatory review," said Brian Caveney, M.D., EVP and president, biopharma laboratory services and chief medical and scientific officer, Labcorp. "Ultimately...

Keep reading with a free account

The rest of this article, and every signal for Labcorp, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Partnership

What this signalsA new partnership often opens integration and co-selling work.

Takes effect
Oct 22, 2026
Location
Burlington, North Carolina, United States

Companies

  • Charles River LaboratoriesPartnercriver.com

The full record

From the Signal API record

Details

Ticker
NYSE:LH

Extraction

Confidence
95%
Detected
Oct 22, 2026
signal_type
news
signal_subtype
partners_with

Use this data

Get every partnership signal for Labcorp and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Labcorp this week?”

  2. Send it to your own tools

    The Signal API returns partnership signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/da7d4eed-37db-e074-b25f-275c9f37180d returns this record as JSON. POST /v1/companies/enrich returns every signal for labcorp.com.

{
  "signal_id": "da7d4eed-37db-e074-b25f-275c9f37180d",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-10-22T20:30:00+00:00",
  "company": {
    "name": "Labcorp",
    "domain": "labcorp.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/labcorp-charles-river-and-fda-announce-research-collaboration-to-advance-preclinical-methods-for-evaluating-drug-abuse-potential-302917291.html",
    "title": "Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential",
    "ticker": "NYSE:LH",
    "excerpt": "Research collaboration aims to strengthen the science used to assess whether new medicines could be abused, supporting safer drug development and more informed regulatory decisions BURLINGTON, N.C. , Oct. 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH ), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the U.S. Food and Drug Administration (FDA) and Charles River Laboratories to advance the science used to evaluate a medicine's abuse potential, or the likelihood that it could be abused. The research aims to support safer drug development and more informed regulatory decisions. The collaboration brings together complementary expertise from industry and government. Labcorp will contribute its experience conducting regulatory abuse potential studies, while FDA scientists will conduct data analysis and contribute regulatory science expertise. Together, the organizations aim to advance the science used to evaluate the risk that a medicine could be abused using harmonized behavioral economics methodology to quantify and rank abuse potential. \"This research has the potential to improve how abuse-related risks are evaluated and inform decisions throughout drug development and regulatory review,\" said Brian Caveney, M.D., EVP and president, biopharma laboratory services and chief medical and scientific officer, Labcorp. \"Ultimately...",
    "summary": "Labcorp announced a research collaboration with Charles River Laboratories and the FDA to advance preclinical methods for evaluating drug abuse potential.",
    "location": "Burlington, North Carolina, United States",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS1034544/Labcorp-Logo.jpg?id=OA3034969&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-10-22T20:30:00Z",
    "location_data": [
      {
        "city": "Burlington",
        "state": "North Carolina",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-10-22",
    "article_sentence": "Labcorp (NYSE: LH ), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the U.S. Food and Drug Administration (FDA) and Charles River Laboratories to advance the science used to evaluate a medicine's abuse potential, or the likelihood that it could be abused.",
    "related_company_name": "Charles River Laboratories",
    "related_company_domain": "criver.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.